Baker Bros. Advisors’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Baker Bros. Advisors’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-6,760,394	Closed	-$37.3M	–	114
2014 Q1	$37.3M	Buy	6,760,394 +965,641	+17%	+$4.85M	0.47%	31
2013 Q4	$25.7M	Hold	5,794,753	–	–	0.36%	31
2013 Q3	$17.3M	Buy	5,794,753 +1,018,966	+21%	+$2.93M	0.25%	36
2013 Q2	$11M	Buy	+4,775,787	New	+$9.66M	0.22%	35

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Baker Bros. Advisors's CHTP Position: Q2 2014 in Review

Baker Bros. Advisors sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 6,760,394 shares — an estimated $37.3M sold.

Baker Bros. Advisors first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $37.3M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

Baker Bros. Advisors reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
Baker Bros. Advisors sold 6,760,394 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $37.3M.
Baker Bros. Advisors first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
Baker Bros. Advisors's CHELSEA THERAPEUTICS INT'L LTD position peaked at $37.3M in Q1 2014.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Baker Bros. Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.